Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P18
Within normal range
vs 2Y Ago
-32.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -35.59% |
| Q2 2025 | 28.87% |
| Q1 2025 | -21.19% |
| Q4 2024 | -34.82% |
| Q3 2024 | -13.71% |
| Q2 2024 | 5.29% |
| Q1 2024 | -37.50% |
| Q4 2023 | -66.75% |
| Q3 2023 | 1.11% |
| Q2 2023 | 1.75% |
| Q1 2023 | -29.95% |
| Q4 2022 | 0.00% |